BioDuro-Sundia Appoints Dr. Armin Spura as New CEO

Share This Post

Key Highlights

  • Dr. Armin Spura appointed as BioDuro-Sundia’s new CEO
  • Brings over two decades of experience in life sciences and biotechnology
  • Led Crown Bioscience as CEO for five years
  • Previously held leadership roles at Thermo Fisher Scientific, WuXi NEXTCODE, CareDx, and Ion Torrent
  • BioDuro-Sundia offers fully integrated CRDMO services from discovery to commercial manufacturing

Source: Business Wire

Notable Quotes

  • “With our unique, fully integrated CRDMO platform — encompassing chemistry, biology, DMPK, drug substance, and drug product from discovery through to commercial manufacturing — I am confident we will empower more partners to bring better treatments to patients around the world faster.” — Dr. Armin Spura, CEO at BioDuro-Sundia
  • “Dr. Spura’s extensive global experience and visionary leadership is instrumental in driving BioDuro-Sundia’s accelerated growth.” — Gary Chu, Chairman of the Executive Operation Committee at BioDuro-Sundia

SoHC's Take

The appointment of Dr. Armin Spura as CEO marks a strategic move for BioDuro-Sundia. With his proven track record in scaling companies and fostering innovation, particularly through his leadership at Crown Bioscience, BioDuro-Sundia is poised to accelerate its growth in the CRDMO sector. As the company strengthens its global presence, Spura’s leadership will likely play a pivotal role in expanding their integrated solutions and addressing the evolving needs of the life sciences industry. This leadership change could further enhance BioDuro-Sundia’s position as a leading CRDMO in the global market.

Heading

Key Highlights Ginkgo Bioworks releases first proprietary protein LLM, trained on exclusive datasets.Collaboration with Google Cloud enables AI-driven drug discovery tools.Open API allows researchers to access Ginkgo’s machine ...
/
Key Highlights Courtney Green joins QGenda as Vice President of Nurse and Staff Solutions.Brings over 20 years of clinical and operational leadership experience.Focus on optimizing ...
/
Key Highlights Vyne Medical® acquires Extract Systems®, a leader in data extraction solutions.Accelerates healthcare automation by integrating AI and machine learning ...
/
Key Highlights PatientPay integrates with Azalea Health’s API to streamline patient billing for ambulatory providers.Faster revenue capture with less than 14 days to payment, ...
/
Key Highlights Partnership streamlines revenue cycle management for ABA therapy providers.Flychain’s financial tools offer real-time insights, secure funding, and automation.Raven ...
/
Key Highlights Nura Bio closes $140M Series A financing to support clinical development.Shilpa Sambashivan, Ph.D., appointed as CEO following Phase 1 success ...
/

More To Explore

Total
0
Share